Antenatal Steriod Administration

17% of survey complete.

Please select the single best answer to each question. To obtain continuing education credits, complete this on-line post test, evaluation and continuing education validation information.

Question Title

* 1. The primary goals of antenatal steriod administration is:

Reduce the risk of maternal infection.

Improve severity of respiratory illness in preterm infants.

Reduction in overall mortality and the incidence of IVH.

B and C are correct.

Question Title

* 2. The benefit of antenatal corticosteroid use in preterm pregnancy has not been shown to exceed the risk and therefore caution should be used in consideration of candidates for treatment.

True

False

Question Title

* 3. Weekly administration of ANS is associated with which of the following?

Smaller fetal head size

Lower birthweight

Significant improvement in outcome over single course treatment

A & B both

Question Title

* 4. An elevated risk of head and somatic growth delay from ANS treatment is seen with how many courses?

One course

Two courses

More than 2 courses

More than 5 courses

Question Title

* 5. True or false: Decisions regarding use of ANS should take gender, race and availability of good NICU care into consideration when identitfying appropriate candidates for treatment.

True

False

Question Title

* 6. If preterm delivery (24-34 weeks) is anticipated in less than 24 hours, consideration of ANS use is:

Not indicated as the full course can not be administered

Indicated as treatment for less than 24 hours can be associated with significant reduction in neonatal mortality as well as RDS and IVH.

Question Title

* 7. True or False: Betamethasone is the first choice of steroid for ANS because fewer injections are needed and much of the outcome data for ANS was done using betamethasone instead of dexamethasone.

True

False

Question Title

* 8. Which of the following are accurate medication administration regimes for ANS?

Betamethasone 12 mg, intramuscular injection, two doses, 24 hours apart.

Dexamethasone, 6 mg, intramuscular injection, four doses, 12 hours apart.

All of the above

Neither of the above

Question Title

* 9. True or false: ANS treatment may be indicated after 34 weeks gestation in specific circumstances, in the presence of an immature lung profile.

True

False

Question Title

* 10. True or False: ANS may be used in preterm premature rupture of membrances, without clinical chorioamnioitis, at less than 30-32 weeks gestation.

True

False

Question Title

* 11. True or false: Regardless of the risk to the mother, ANS should be given to all patients when delivery is imminent prior to 34 weeks.

True

False